Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Entera Bio Ltd (NASDAQ: ENTX) closed the day trading at $2.38 down -4.42% from the previous closing price of $2.49. In other words, the price has decreased by -$4.42 from its previous closing price. On the day, 67437.0 shares were traded. ENTX stock price reached its highest trading level at $2.49 during the session, while it also had its lowest trading level at $2.34.
Ratios:
For a better understanding of ENTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.83 and its Current Ratio is at 10.83. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Aegis Capital on March 22, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENTX now has a Market Capitalization of 109140240 and an Enterprise Value of 100777232. For the stock, the TTM Price-to-Sale (P/S) ratio is 909.47 while its Price-to-Book (P/B) ratio in mrq is 7.13. Its current Enterprise Value per Revenue stands at 812.72 whereas that against EBITDA is -9.34.
Stock Price History:
The Beta on a monthly basis for ENTX is 1.72, which has changed by 0.51829267 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, ENTX has reached a high of $3.22, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -0.84%, while the 200-Day Moving Average is calculated to be 14.89%.
Shares Statistics:
Over the past 3-months, ENTX traded about 156.80K shares per day on average, while over the past 10 days, ENTX traded about 81070 shares per day. A total of 45.66M shares are outstanding, with a floating share count of 34.66M. Insiders hold about 24.43% of the company’s shares, while institutions hold 20.05% stake in the company. Shares short for ENTX as of 1763078400 were 162978 with a Short Ratio of 1.04, compared to 1760486400 on 96923. Therefore, it implies a Short% of Shares Outstanding of 162978 and a Short% of Float of 0.41000000000000003.
Earnings Estimates
The market rating for Entera Bio Ltd (ENTX) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.32 and -$0.32 for the fiscal current year, implying an average EPS of -$0.32. EPS for the following year is -$0.67, with 1.0 analysts recommending between -$0.67 and -$0.67.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for ENTX’s current fiscal year. The highest revenue estimate was $42k, while the lowest revenue estimate was $42k, resulting in an average revenue estimate of $42k. In the same quarter a year ago, actual revenue was $181k
